Concepedia

Saritha C. Thumma

SC

Statistics

Publications

4

Citations

260

H-Index

4

Active since

2007

Affiliations

Eli Lilly (United States)(Current)

University of Minnesota Medical Center

Saritha C. Thumma is an author at Eli Lilly (United States) specializing in cancer cell signaling, molecular oncology, and oncology.

Publications per year

2007–2018

4

Publications

4

Abnormal RNA stability in amyotrophic lateral sclerosis

EM Tank, Claudia Figueroa‐Romero, Lucy M. Hinder et al. · Nature Communications · 2018 · 162 citations · Full text

, , +17

Targeting Eukaryotic Translation in Mesothelioma Cells with an eIF4E-Specific Antisense Oligonucleotide

Blake A. Jacobson, Saritha C. Thumma, Joseph Jay-Dixon et al. · PLoS ONE · 2013 · 35 citations · Full text

, , +10

Ras Pathway Activation in Malignant Mesothelioma

Manish R. Patel, Blake A. Jacobson, Arpita De et al. · Journal of Thoracic Oncology · 2007 · 34 citations · Full text

, , +14

Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells

Saritha C. Thumma, Bruce A. Jacobson, Manish R. Patel et al. · Cancer Gene Therapy · 2015 · 29 citations

, , +17

1–4 of 4